|1.||Thiemermann, Christoph: 14 articles (01/2007 - 12/2002)|
|2.||Lin, Mao-Tsun: 12 articles (05/2011 - 12/2005)|
|3.||Chayama, Kazuaki: 10 articles (12/2014 - 01/2010)|
|4.||Huang, Yi-Hsiang: 9 articles (11/2015 - 10/2009)|
|5.||Okusaka, Takuji: 9 articles (07/2015 - 11/2002)|
|6.||Ikeda, Masafumi: 9 articles (03/2014 - 11/2002)|
|7.||Cuzzocrea, Salvatore: 9 articles (10/2012 - 12/2002)|
|8.||Collin, Marika: 9 articles (01/2007 - 03/2004)|
|9.||Lin, Han-Chieh: 8 articles (11/2015 - 10/2009)|
|10.||Kubo, Shoji: 8 articles (01/2014 - 03/2003)|
|1.||Body Weight (Weight, Body)
09/01/2011 - "Average hematocrit, albumin, aspartate aminotransferase, and body weight remained unchanged. "
03/15/2006 - "Furthermore, gold-1a treatment neither caused significant drop in body weight of the rats nor affected plasma aspartate aminotransferase level. "
11/01/2005 - "Body weight gain, food intake, liver and spleen weights, as well as LFTs [except aspartate aminotransferase (AST)] did not differ among the four groups. "
04/01/2000 - "Although the plasma aspartate aminotransferase (AST) activities tended to decrease from 1 to 4 weeks post-surgery, no abnormality was noted in clinical sign, body weight, the hematocrit value or other blood chemical values. "
02/01/1988 - "Total liver enzyme activity (E) for aspartate aminotransferase (ASAT; EC 126.96.36.199) per gram body weight (W) decreases in six species as body weight increases from mice to cattle according to the equation E/W 0.85 = c, where c is a constant. "
02/01/2015 - "Our predictive models, which were based on analytic morphomics and demographics (morphomics model) or analytic morphomics, demographics, and laboratory studies (full model), identified patients with cirrhosis with area under the receiver operating characteristic curve (AUROC) values of 0.91 and 0.90, respectively, compared with 0.69, 0.77, and 0.76 for aspartate aminotransferase-to-platelet ratio, Lok Score, and FIB-4, respectively, by using the same data set. "
01/01/2015 - "This study described an index of aspartate aminotransferase-to-platelet ratio index (APRI) to assess hepatic fibrosis with limited expense and widespread availability compared to the liver biopsy in adolescent patients with CHB. "
09/01/2014 - "The aim of this study was to find the correlation of LSM, aspartate transaminase to platelet ratio index (APRI) with fibrosis as assessed by liver biopsy (LB), and predictors of discordance between LB and LSM. "
05/01/2011 - "The study of noninvasive markers of fibrosis, such as aspartate aminotransferase (AST) to platelet ratio index (APRI), have been limited in African American populations. "
11/01/2015 - "To assess the diagnostic value of a 3D dual-flip-angle (DFA) T1 mapping technique with whole liver coverage before and after gadoxetic acid injection for assessment of cirrhosis and liver function, compared to blood tests (APRI: aspartate aminotransferase-to-platelet ratio index). "
|3.||Liver Diseases (Liver Disease)
09/01/2013 - "The aim of this study was to analyze the use of a noninvasive test, the aspartate aminotransferase to platelet ratio index (APRI), in the diagnosis of liver disease in pediatric patients with IF. "
09/01/1982 - "The very high incidence of abnormal SGC values found in this study does suggest that in an ordinary inpatient and outpatient service SGC determination is a practical and sensitive indicator of the presence of significant liver disease but for its comprehensive identification aspartate transaminase and gammaglutamyl transpeptidase must also be determined."
08/01/2015 - "We tested for an interaction between SVR and liver disease severity (mild vs. nonmild), defining mild disease as an aspartate aminotransferase-to-platelet ratio index (APRI) <0.7. "
01/01/2012 - "Development of an electrochemical-based aspartate aminotransferase nanoparticle ir-C biosensor for screening of liver diseases."
12/01/2011 - "What is the performance of the Aspartate Aminotransferase to platelets Ratio Index in patients With Chronic Liver Disease?"
09/28/2012 - "HCV-infected patients had higher hepatitis activity (aspartate transaminase levels 108.77 ± 60.73 vs 23.19 ± 5.47, P < 0.01; ALT levels 168.69 ± 93.12 vs 23.15 ± 9.45, P < 0.01) and lower platelet count (170.40 ± 58.00 vs 251.24 ± 63.42, P < 0.01) than controls. "
01/01/2005 - "Comparison of acute form fulminant hepatitis with the subacute form and LOHF showed OPN expression in proliferated bile ductules and serum aspartate aminotransferase (ALT)max to be decreased in the subacute form of fulminant hepatitis. "
06/01/1993 - "The SGOT elevations were minimal and were not related to the occurrence of clinical hepatitis: No clinical hepatitis occurred."
03/01/1991 - "Results show that a benign elevation of aspartate transaminase occurs in up to 50% cases, that the reaction can be a symptomatic one and that clinical hepatitis can occasionally result. "
02/01/1990 - "Twenty-nine patients of 18,000 inpatient admissions over a six-month period developed ischaemic hepatitis accompanied by peak aspartate aminotransferase (AST-EC 188.8.131.52) activity greater than 1,000 U/L. "
10/12/1995 - "Remission was defined as the absence of symptoms suggestive of a relapse and serum globulin and aspartate aminotransferase concentrations within the normal range, with or without a liver biopsy showing only minimal inflammation. "
06/01/1996 - "The aim of the present study was to evaluate the association between the outcome of a chairside test measuring gingival crevicular fluid (GCF) levels of the enzyme aspartate aminotransferase (AST) and other clinical measures of disease including probing depth, severity of inflammation, and GCF flow before and after therapy. "
03/01/1990 - "We report the results of studies aimed at determining whether levels of the enzyme aspartate aminotransferase (AST) in gingival crevicular fluid (GCF) are associated with disease activity as assessed by the level of gingival inflammation and probing attachment loss. "
04/01/2012 - "Elevated aspartate transaminase in absence of inflammation indicated that hepatocellular turnover in the liver might drive the loss of vector genomes. "
05/01/2010 - "Mice receiving DAF-displaying baculovirus also exhibited lower level of liver inflammation as evidenced by aspartate aminotransferase (AST). "
|1.||Alanine Transaminase (SGPT)
|7.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|8.||gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)
|9.||Aspartate Aminotransferases (Aspartate Transaminase)